NCT01461148View on ClinicalTrials.gov

Vaccination Against MSI Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

May 31, 2015

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

FSP peptides

100 ug of each FSP (TAF1B(-1), HT001(-1) and AIM2(-1), weekly for 4 consecutive weeks and repeated every four weeks up to a total of 3 cycles.

Trial Locations (1)

60488

Krankenhaus Nordwest, Frankfurt am Main

All Listed Sponsors
lead

Oryx GmbH & Co. KG

INDUSTRY

NCT01461148 - Vaccination Against MSI Colorectal Cancer | Biotech Hunter | Biotech Hunter